U.S. FDA - Drug Shortages (sign up for drug shortage email noticiations)

• Sign up for Drug Shortages E-mail Notifications

Email Updates

Welcome to the U.S. Food & Drug Administration (FDA) free e-mail subscription service. When you subscribe to this service, you will receive an e-mail message each time there is an update on the FDA page(s) you select.
To subscribe to this service or update your subscriber preferences, please enter your e-mail adddress below. You may change your subscriber preferences or cancel your subscription at any time.
We have a strict privacy policy. FDA does not collect personally identifiable information other than your e-mail address which is needed in order to provide the service. FDA will not use or share your e-mail address for any other purpose. The GovDelivery service FDA employs to provide this e-mail subscription service is not a government entity. Information you provide may be made available to GovDelivery and other non-governmental parties.

1. Email Address

Your contact information is used to deliver requested updates or to access your subscriber preferences.

Drug Shortages

FDA takes great efforts, within its legal authority, to address and prevent drug shortages, which can occur for many reasons, including manufacturing and quality problems, delays, and discontinuations. The agency works closely with manufacturers of drugs in short supply to communicate the issue and to help restore availability. FDA also works with other firms who manufacturer the same drug, asking them to increase production, if possible, in order to prevent or reduce the impact of a shortage.
Manufacturers are not required to report information, such as reasons for shortages or the expected duration of shortages. However, many companies voluntarily provide shortage information that FDA posts on its website. FDA encourages and appreciates all reporting of shortages by manufacturers. Shortage notifications and updates may be reported to FDA at drugshortages@fda.hhs.gov.